Page 16 - ஆன்டிபாடி காக்டெய்ல் பயன்படுத்தப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆன்டிபாடி காக்டெய்ல் பயன்படுத்தப்பட்டது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆன்டிபாடி காக்டெய்ல் பயன்படுத்தப்பட்டது Today - Breaking & Trending Today

Welcome To IANS Live - SCIENCE AND TECHNOLOGY - Electrochemical ELISA: Novel test for total Covid antibody concentration


Photo Credit: IANS
IANSLive
New Delhi, May 22 (IANS) In a first of its kind technology, a test would now help rapid and accurate estimation of total antibody concentration of Covid-19 in clinical samples.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 22-May-2021 ....

New Delhi , News Service , India Private , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Monoclonal antibody bamlanivimab reduces hospitalization and death in moderate-to-severe COVID-19


Monoclonal antibody bamlanivimab reduces hospitalization and death in moderate-to-severe COVID-19
Monoclonal antibody treatment may help prevent coronavirus disease (COVID-19) complications. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infection has now caused over 164 million cases globally.
Researchers at the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center found that monoclonal antibodies, a COVID-19 treatment administered early after infection, reduce the risk of hospitalization and death by 60 percent in people at high risk of suffering complications from the condition.
Published in the journal
Open Forum Infectious Diseases, the team aimed to quantify the impact of bamlanivimab monoclonal antibody monotherapy on hospitalization and mortality among outpatients at high-risk COVID-19 complications. ....

Abcellera Biologics , Graham Snyder , Eli Lilly , Angela Betsaidab Laguipo , Emergency Department , Forum Infectious Diseases , University Of Pittsburgh School Medicine , University Of Pittsburgh Medical Center , Drug Administration , Pitt School Of Medicine , Angela Betsaida , Pittsburgh School , Pittsburgh Medical Center , Open Forum Infectious Diseases , Monoclonal Antibody , Coronavirus Disease Covid 19 , Immune System , Infectious Diseases , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , கிரஹாம் ஸ்னைடர் , எலி லில்லி , அவசரம் துறை , மன்றம் தொற்று நோய்கள் , பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் பள்ளி மருந்து ,